Enrichment Program

The Effect Of Drug Dx23 Towards Enhancing Neutrophil Function And Regulating Immune Response

---

Neutrophils are the main cells that play a significant role in the innate immune system. Upon a pathogenic invasion, these cells are recruited to the site of infection and perform many different functions. Targeting the neutrophils for therapeutic interventions has been a great challenge due to the complexity of their signaling pathway and mechanisms. Therefore, the search for drug candidates that enhance neutrophil function remains questionable. DX23 is a type of CFTR potentiator originally used to treat patients with cystic fibrosis However, this research would like to test the potential of DX23 as one of the drug candidates tested for enhancing neutrophil activity. Moreover, the experiment utilizes spectrophotometry, flow cytometry, and luminometer to elucidate the molecular mechanisms underlying the responses of neutrophils and identify targets for treating neutrophil-associated diseases. In this study, DX23 was found to enhance superoxide anion production, reactive oxygen species generation, and elastase release in human neutrophils. Additionally, DX23 is able to promote the formation of NETs in order to initiate immune defense. Further study also shows that DX23 promotes the generation of primary and secondary granules during degradation in CD marker detection.

---

Availability

Detail Information

Series Title

-

Call Number

EP BM-005

Publisher

i3L, Jakarta : i3L, Jakarta., 2024

Collation

-

Language

English

ISBN/ISSN

-

Classification

EP BM-005

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

immune response
Neutrophils
DX23
enhancing
novel drug target
activation

Specific Detail Info

-

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment